- Home
- TMP vs RLAY Comparison
TMP vs RLAY Comparison
Compare TMP & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMP
- RLAY
- Stock Information
- Founded
- TMP 1836
- RLAY 2015
- Country
- TMP United States
- RLAY United States
- Employees
- TMP N/A
- RLAY N/A
- Industry
- TMP Major Banks
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TMP Finance
- RLAY Health Care
- Exchange
- TMP Nasdaq
- RLAY Nasdaq
- Market Cap
- TMP 1.0B
- RLAY 811.8M
- IPO Year
- TMP N/A
- RLAY 2020
- Fundamental
- Price
- TMP $68.68
- RLAY $3.92
- Analyst Decision
- TMP Buy
- RLAY Strong Buy
- Analyst Count
- TMP 2
- RLAY 10
- Target Price
- TMP $69.00
- RLAY $20.11
- AVG Volume (30 Days)
- TMP 47.8K
- RLAY 1.4M
- Earning Date
- TMP 01-31-2025
- RLAY 02-28-2025
- Dividend Yield
- TMP 3.58%
- RLAY N/A
- EPS Growth
- TMP 653.03
- RLAY N/A
- EPS
- TMP 4.97
- RLAY N/A
- Revenue
- TMP $292,618,000.00
- RLAY $10,006,000.00
- Revenue This Year
- TMP N/A
- RLAY N/A
- Revenue Next Year
- TMP $8.22
- RLAY N/A
- P/E Ratio
- TMP $13.92
- RLAY N/A
- Revenue Growth
- TMP 35.84
- RLAY N/A
- 52 Week Low
- TMP $43.09
- RLAY $3.50
- 52 Week High
- TMP $79.01
- RLAY $10.89
- Technical
- Relative Strength Index (RSI)
- TMP 46.35
- RLAY 41.60
- Support Level
- TMP $68.56
- RLAY $3.85
- Resistance Level
- TMP $70.76
- RLAY $4.19
- Average True Range (ATR)
- TMP 1.90
- RLAY 0.28
- MACD
- TMP -0.16
- RLAY -0.02
- Stochastic Oscillator
- TMP 26.67
- RLAY 24.80
About TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).